Recurrent ESR1 fusion transcripts are associated with endocrine resistance in estrogen receptor positive, HER2 negative breast cancer

This article has no abstract
Epistemonikos ID: 6ebd4518910eb920b59813b9bda31c343086bc88
First added on: Feb 07, 2025